cerrar
Tagged with Oncology

Japan Oncology Market Snapshot 2021
While the overall Japanese pharma market is expected to remain at a similar overall value up to 2023, the oncology segment is expected to grow by five…

Şeyda Atadan Memiş – General Manager, Takeda Turkey
Takeda’s general manager for Turkey, Şeyda Atadan Memiş, reflects on the Japanese giant’s ambitions in Turkey at a pivotal moment when the Shire…

Ashok Venkitaraman – Director, Cancer Science Institute of…
Professor Ashok Venkitaraman introduces his work in Singapore, coordinating and catalysing research on the causes of cancer in Asia, and translating…

Simranjit Singh – CEO, Guardant Health AMEA
Simranjit Singh highlights Guardant Health’s role in the global precision oncology landscape and how the company leverages its proprietary blood…

New China President for MSD Amid Changes at HQ & Access…
MSD, which has had a presence in China since 1990, recently appointed Belgian national Anna van Acker to lead its strategically important China…

EU’s Beating Cancer Plan: Making it Our Own
Jasper Kunow, MSD’s managing director for Central Eastern Europe, outlines the threat that cancer still poses to Europe, the challenges of enacting…

Dun Yang – President & CEO, Anticancer Bioscience
Anticancer Bioscience is an exciting international precision oncology company, applying synthetic lethal approaches to develop targeted cancer…

Annie Tan – General Manager, Singapore, Thailand &…
Annie Tan highlights the strategy she laid out to navigate the BMS Singapore, Thailand and Malaysia affiliates through the COVID-19 pandemic; the…

Michael Bauer – CEO & Board Member, Cellestia
Dr Michael Bauer, a Novartis early development veteran, now serves as CEO of Basel-based Cellestia. Here, Bauer explains why Cellestia’s unique…

Piers Ingram – Co-Founder & CEO, Hummingbird…
Dr Piers Ingram, PhD, co-founder, and CEO of Singapore-based biotech Hummingbird Bioscience, shares his motivation for establishing the company in…

China: EpimAb Looks to 2022 IPO & Global Leadership in…
Hot on the heels of a USD 120 million fundraising round, Shanghai-based EpimAb Biotherapeutics is now looking towards a 2022 IPO with the aim of…

Sizhen Wang – CEO & Co-Founder, Genetron Health
Genetron Health is a publicly-traded China-based precision oncology company, covering the “full-cycle” of cancer care, from early screening,…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here